Navigation Links
Lowering Blood Pressure Improves Brain Hemorrhage Outcomes
Date:4/4/2008

Aggressive action is safe and may cut risk of disability, death, study finds

FRIDAY, April 4 (HealthDay News) -- Intravenous treatment to drastically lower the blood pressure of people who've just suffered bleeding in the brain may improve their prognosis, a pilot study suggests.

Intracranial hemorrhage often causes a rapid rise in blood pressure, which may contribute to further bleeding and the growth of the hematoma (an area of internal bleeding). This can cause the patient's condition to deteriorate and increase the risk of disability or death, according to background information in the study.

Although it's recommended to lower very high blood pressure as soon as possible in patients with intracranial hemorrhage, there is little evidence on when to start treatment or how much to lower blood pressure. This leads to wide variations in the management of high blood pressure in these patients.

This study compared intensive blood-pressure lowering treatment (target systolic blood pressure 140mm Hg) in 203 patients to the recommended best practice standard strategy (target systolic blood pressure 180 mm Hg) in 201 patients.

Brain scans conducted 24 hours after the start of treatment showed hematoma growth of 13.7 percent in the intensive treatment group, compared with 36.6 percent in the non-intensive group.

There were no differences between the two groups in terms of harmful side effects, rates of death and disability, or quality of life for survivors after 90 days.

"Because intravenous treatment to lower blood pressure is relatively straightforward, is not hazardous, and is of low cost, if applied widely, these effects could translate into major absolute benefits," concluded Dr. Craig Anderson, of the George Institute for International Health in Sydney, Australia, and colleagues.

The study was expected to be published in the May issue of The Lancet Neurology.

I
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2

Related medicine news :

1. Stanford study highlights cost-effective method of lowering heart disease risks
2. Lowering Blood Protein Wont Help Kidney Patients
3. Abbotts Investigational SIMCOR(R) Offers Comparable LDL Lowering to Simvastatin and Significantly Raises HDL and Lowers Triglycerides in Phase III Study
4. Cholesterol-lowering drug linked to sleep disruptions
5. Many Patients Stop Taking Cholesterol-Lowering Drugs
6. Amount of Exercise Key to Lowering Kids Blood Pressure
7. New Type of Cholesterol-Lowering Drug Shows Promise
8. Lowering Co-Pays on Some Drugs Help Fight Chronic Diseases
9. Cholesterol-Lowering Drugs May Ease Irregular Heartbeat
10. Cholesterol-Lowering Statins Tied to Tendon Woes
11. Study shows cholesterol-lowering power of dietitian visits

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... Global measles deaths dr... (Vocus) December 1, 2009 -- WHAT: Meas..., U.S. Centers for Disease Control and Prevention,...rld Health Organization – will announce the ...leconference on Thursday, December 3, 2009 at 10:0...
(Date:12/1/2009)..., , RANCHO SANTA FE, Calif., Dec. 1 /...resveratrol, the ingredient in grapes acclaimed fo...is about to hit the marketplace. ,, (Photo: ht... ) ,, (Logo: http://www.newscom.com/cgi-bin/p...WINETIME(TM) Bar, developed by ResVez, Inc. of Ran...
(Date:12/1/2009)..., , SAN DIEGO, Dec. 1 /PRNewswire-Firs...d supplier of Farming, Nursery and Wellness produc...g agreement with Southern California Micro-Lending...). ,, Yan Skwara, CEO of US Farms, Inc. stated...artnership with Angels in Action utilizing our Alo...
(Date:12/1/2009)..., , BRUSSELS, December 1 /PRNewswire/...rts Agree That Adapting Food,Production and Modes ...s , Prof. John Beddington, Chief Scientif... agricultural policy must be founded on science an...entific advisor with the,responsibility to look at...
(Date:12/1/2009)...Some become so worried about what might happen tha... , TUESDAY, Dec. 1 (HealthDay News) -- Fe...to depression, a new study suggests. , "Anxiety...y author Andres Viana, a graduate student in psych...e with anxiety sensitivity are afraid of their anx...
Breaking Medicine News(10 mins):Health News:**MEDIA ADVISORY** Measles Initiative to Announce Major Achievement in Public Health 2Health News:First Resveratrol Nutrition Bar Hits the Market 2Health News:US Farms, Inc. Announces Marketing Agreement With Micro Lending Institution Angels In Action 2Health News:US Farms, Inc. Announces Marketing Agreement With Micro Lending Institution Angels In Action 3Health News:Food Security to be the Top Issue for EU's Science Chief 2Health News:Fear of Anxiety May Lead to Depression 2
...Americans Report Communication about Delays Bigges...ement, SOUTH BEND, Ind., June 10 Press Ganey Ass...rovider of quality improvement,solutions, today re...ts and also indicate that communication about,dela...
..., New York, NY, June 10th, 2008The number of unde...r, but also very high medical expenses relative to...2007, from 16 million to more than 25 million, acc...e steep increase: underinsured rates nearly triple...
...Campaign educates consumers to ,check before writi... Division of,Insurance is addressing the health ca...sing, by promoting their consumer education awaren...ultimedia News Release, go to:, http://www.prnewsw...
...,TRX(R) Biomechanics: Healthy Back, improves back ...ty, flexibility and alignment. ,TRX(R) Performanc..., training workout that can be done on the court,...g born,within the US Navy SEAL teams, has just rel...
...CHICAGO, June 9 Specialty Underwriters,Alliance, ...y, SUA Insurance,Company ("SUA"), has entered into...demnity Co. to provide general liability to compan... into a second arrangement with American Safety,ex...
...Relief efforts underway throughout Midwest, but al...nd heavy rainfall,have caused serious flash floodi...d States. In response, the American Red Cross has ...ship and,economic loss., Relief efforts are alrea...
Other Medicine News:Health News:Authoritative Report on Emergency Department Experiences Released Today 2Health News:Authoritative Report on Emergency Department Experiences Released Today 3Health News:Insured but poorly protected: 25 million adults are underinsured 2Health News:Insured but poorly protected: 25 million adults are underinsured 3Health News:Video: The Nevada Division of Insurance Launches 2008 'Health Sham' Insurance Campaign 2Health News:Video: The Nevada Division of Insurance Launches 2008 'Health Sham' Insurance Campaign 3Health News:Fitness Anywhere, Maker of the TRX Suspension Trainer(TM), Releases Two New Specialized Training Programs 2Health News:Fitness Anywhere, Maker of the TRX Suspension Trainer(TM), Releases Two New Specialized Training Programs 3Health News:SUA Insurance Company Announces Partnership With American Safety Indemnity Company 2Health News:SUA Insurance Company Announces Partnership With American Safety Indemnity Company 3Health News:American Red Cross Responds to Floods and Tornadoes in Central United States 2Health News:American Red Cross Responds to Floods and Tornadoes in Central United States 3
(Date:12/1/2009)..., Dec. 1 Micromet, Inc. ...loping novel, proprietary antibodies for the treat...es today announced that Bayer Schering Pharma AG h...ation and license agreement entered into on Januar...treatment of solid tumors. ,, Under the terms o...
(Date:11/30/2009)...ov. 30 DATATRAK Internat...es company focused on global eClinical solutions f...hat PFC Pharma Focus AG (PFC) has joined its CRO C...ontract for DATATRAK,s CRO partner training and of... suite. In addition, PFC will also have access to...
(Date:11/30/2009).... 30 Breast-Specific Gamma Imaging... of malignant or high-risk lesions in patients wit... according to results of a multicenter study prese...al Society of North America (RSNA). ,, In this ...nct diagnostic imaging modality at four institutio...
Breaking Medicine Technology:Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 2Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 3Bayer Schering Exercises Option to Develop Solid Tumor BiTE Antibody with Micromet 4PFC Pharma Joins DATATRAK's CRO Connect Program 2PFC Pharma Joins DATATRAK's CRO Connect Program 3PFC Pharma Joins DATATRAK's CRO Connect Program 4BSGI Makes Significant Impact on Detection of Breast Cancer in Patients with Negative Mammographic Findings 2Brain Injury Association of New York State to Host Kick Off Cocktail Reception 56138 1Brain Injury Association of New York State to Host Kick Off Cocktail Reception 56138 2Helix Biopharma to Present at the Rodman 26 Renshaw 11th Annual Healthcare Conference 13831 1Helix Biopharma to Present at the Rodman 26 Renshaw 11th Annual Healthcare Conference 13831 2Helix Biopharma to Present at the Rodman 26 Renshaw 11th Annual Healthcare Conference 13831 3Dominion Diagnostics to Host Open House Reception in New Vermont Laboratory Facility 56131 1Dominion Diagnostics to Host Open House Reception in New Vermont Laboratory Facility 56131 2
...daq: MEDX ) today announced preliminary data from...evelopment code of Ono Pharmaceutical Co.,Ltd.), a...om patients with,recurrent or treatment-refractory...ity and pharmacokinetic profile of single-dose MDX...umor activity was observed,including one patient w...
...eting - - Conference call to be hosted Wednesday,... discuss results -, BRANFORD, Conn., June 1 C...d encouraging results from the ongoing Phase,I/II ...table Stage III or,Stage IV melanoma. The results ...estigator, and Professor, Chairman, Dept. of Melan...
Other Medicine Technology:Preliminary Data from Ongoing Phase 1 Data of Investigational Anti-PD-1 Antibody Presented at American Society of Clinical Oncology Annual Meeting 2Preliminary Data from Ongoing Phase 1 Data of Investigational Anti-PD-1 Antibody Presented at American Society of Clinical Oncology Annual Meeting 3Preliminary Data from Ongoing Phase 1 Data of Investigational Anti-PD-1 Antibody Presented at American Society of Clinical Oncology Annual Meeting 4CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma 2CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma 3CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma 4CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma 5CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma 6
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
...nal reference laboratory and a worldwide leader in...RUP offers an extensive test menu of highly comple...c pathology. Owned by the University of Utah, ARUP...he nation's university teaching hospitals and chil...
Medicine Products: